(RTTNews) - Citi Trends, Inc. (CTRN), a discount retailer ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...

Citi initiated coverage of ServiceTitan (TTAN) with a Neutral rating and $109 price target ServiceTitan is a vertical software-as-a-service company focused on providing purpose-built software for ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Citi lowered the firm’s price target on Generac (GNRC) to $162 from $172 and keeps a Neutral rating on the shares. The firm also added a “90-day negative catalyst watch” on the shares. Citi ...

Citi analyst Anthony Pettinari upgraded Azek (AZEK) to Buy from Neutral with a price target of $60, up from $51. The firm cites is its above-consensus 2025 estimates, and attractive relative ...

Citi initiated coverage of EyePoint (EYPT) with a Buy rating and $33 price target. The firm expects both EyePoint and competitor Ocular Therapeutix (OCUL) to capture meaningful share in wet age ...

Citi analyst Vikram Bagri upgraded HASI (HASI) to Buy from Neutral with a $36 price target The firm says the company is more insulated from potential policy changes. Utility scale companies are ...

Fintel reports that on January 7, 2025, Truist Securities initiated coverage of Citigroup (WBAG:CITI) with a Buy recommendation. What is the Fund Sentiment? There are 2,874 funds or institutions ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

BofA analyst Ebrahim Poonawala raised the firm’s price target on Citi (C) to $95 from $90 and keeps a Buy rating on the shares. Despite a 33% move in the stock last year, the firm’s ...

The firm, which also notes that its 2025 EPS median estimate for the group is 4% above the Street view, identifies Citi (C) as it most preferred stock into earnings and top pick among large cap ...

Citi initiated coverage of West Pharmaceutical (WST) with a Buy rating and $400 price target West is a provider of packaging and injectable solutions and services for the pharmaceutical industry ...